— Know what they know.
Not Investment Advice

FMTX NASDAQ

Forma Therapeutics Holdings, Inc.
1W: +0.3% 1M: +0.4% 3M: +126.9% 1Y: +11.2%
$20.01
Last traded 2022-10-13 — delisted
NASDAQ · Healthcare · Biotechnology

Cash Flow Trends

Operating Cash Flow
-$150M -57.0% ▼
Capital Expenditures
$4M -1578.3% ▼
3Y CAGR: +7.2%
Free Cash Flow
-$154M -60.9% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +100.0% ▲
Net Change in Cash
-$206M -284.6% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2018FY2019FY2020FY2021
— Operating Activities —
Net Income$5M-$35M-$70M-$173M
Depreciation & Amort.$4M$3M$1M$2M
Stock-Based Comp.$0$0$0$0
Change in Working Capital-$144M-$3M-$11M-$3M
Other Non-Cash Items-$1M-$2M-$23M$2M
Operating Cash Flow-$133M-$34M-$95M-$150M
— Investing Activities —
Capital Expenditures-$3M-$529K-$249K-$4M
Acquisitions (Net)$0$0$18M$0
Investment Purchases-$118M-$107M-$480M-$579M
Investment Sales$221M$177M$116M$527M
Other Investing$0$0$46K$0
Investing Cash Flow$99M$69M-$346M-$55M
— Financing Activities —
Net Debt Issuance$0$0$0$0
Stock Repurchased$0$0-$259K$0
Dividends Paid$0$0$0$0
Other Financing$0$55M$553M-$459K
Financing Cash Flow$0$55M$553M-$459K
Net Change in Cash-$34M$90M$111M-$206M
Cash End of Period$84M$174M$285M$80M
Free Cash Flow-$136M-$35M-$96M-$154M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms